Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Tetrasomy 5p is a rare chromosomal anomaly syndrome with variable phenotype principally characterized by developmental delay, growth retardation/short stature, hypotonia, seizures, venriculomegaly, hand and foot anomalies (e.g. clinodactyly, overlapping toes) and mosaic pigmentary skin changes. Patients may also present minor dysmorphic craniofacial features (incl. macrocephaly, upslanting palpebral fissures, hypertelorism, abnormal auricles, anteverted nasal tip, midface hypoplasia).
Features include very common findings: Seizure, Global developmental delay, Neonatal hypotonia, and Cerebellar hypoplasia and others; and common findings: Hypertelorism, Long philtrum, Low-set ears, and Wide nasal bridge and others. 44 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 4 | High blood pressure in lung arteries (pulmonary arterial hypertension), Respiratory distress, Recurrent respiratory infections |
Phenotype severity distribution: 21 very common features, 16 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for tetrasomy 5p.
5 publications have been identified in PubMed for tetrasomy 5p. Research spans Review / Meta-Analysis (40%), Case Report / Case Series (20%), and Basic Science / Preclinical (20%).
Abunaser SMA (2025). [PMID: 40925076](https://pubmed.ncbi.nlm.nih.gov/40925076/). *Cancer Genet*. [Case Report / Case Series]
Buczyńska A (2025). [PMID: 40710310](https://pubmed.ncbi.nlm.nih.gov/40710310/). *Cells*. [Review / Meta-Analysis]
Charras A (2025). [PMID: 39660463](https://pubmed.ncbi.nlm.nih.gov/39660463/). *Curr Opin Rheumatol*. [Review / Meta-Analysis]
Rodrigues PS (2025). [PMID: 40204846](https://pubmed.ncbi.nlm.nih.gov/40204846/). *Sci Rep*. [Basic Science / Preclinical]
Popek-Marciniec S (2025). [PMID: 40115011](https://pubmed.ncbi.nlm.nih.gov/40115011/). *Front Oncol*. [Epidemiology / Natural History]
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 2:44 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Head and neck | 4 | Flat face, High palate, Macrocephaly |
Brain and nerves | 3 | Seizure, Global developmental delay, Hydrocephalus |
Heart and blood vessels | 3 | Congestive heart failure, High blood pressure in lung arteries (pulmonary arterial hypertension), Heart murmur |
Arms and legs | 3 | Overlapping toe, Long fingers, Clinodactyly of the 5th finger |
Growth and development | 2 | Failure to thrive, Postnatal growth retardation |
Skin | 2 | Redundant neck skin, Depigmentation/hyperpigmentation of skin |
Muscles | 1 | Neonatal hypotonia |
Pregnancy and birth | 1 | Neonatal hypotonia |
Blood and immune system | 1 | Recurrent respiratory infections |
Digestive system | 1 | Aplasia/Hypoplasia of the abdominal wall musculature |